Company Profile

We believe a good purpose makes a good business, and good businesses make a better world. Providing reliable products and services is our way to create a brighter future for all.
Our customers specialize in key areas such as basic biological research, disease diagnosis development, biopharmaceuticals and new treatments. Our job is to make it easier for them to improve public health and save lives.
As a young and energetic company, we give 120% in everything we do. We are proud of who we are and what we believe in. We are proud of the difference we made to people’s lives, and to the world.
We are Vazyme.

Our History

2015 Go Global
The International Business Department
was set up with the belief of becoming
the professional supplier of In Vitro
Diagnostic Solutions worldwide.
Nanjing Vazyme Biotech Co.,Ltd.

2019 Biomedical Business
Several key projects of Vazyme
Medical passed the External Quality
Assessment (EQA) of the National
Center for Clinical Laboratories with
full marks.
Nanjing Vazyme Biotech Co.,Ltd.

2021 Listed on SSE
Vazyme went public on the star market
of the Shanghai Stock Exchange under
the stock code 688105.
Nanjing Vazyme Biotech Co.,Ltd.

Nanjing Vazyme Biotech Co.,Ltd.

2012 Found
Vazyme was established including
a number of biomolecular
research reagent product lines with
independent intellectual property
rights.
Nanjing Vazyme Biotech Co.,Ltd.

2016 IVD Business
Vazyme Medical Technology CO.,
LTD was established, which aimed
to deploy IVD testing reagents and
instruments.
Nanjing Vazyme Biotech Co.,Ltd.

2020 Response to COVID-19
COVID-19 Solutions with high detection
sensitivity were developed by Vazyme
professional team and certified by
more and more regions from all over
the world.
Nanjing Vazyme Biotech Co.,Ltd.

2022 Together for Future
Vazyme ranked among the top 500 listed companies in China in 2021, and was ISO 13485 certified. Also, a new branch was established in German to deliver a full range of solutions locally.
Nanjing Vazyme Biotech Co.,Ltd.

Development History

2012

Found

Vazyme was established including

a number of biomolecular

research reagent product lines with

independent intellectual property

rights.

Nanjing Vazyme Biotech Co.,Ltd.

2015

Go Global 

The International Business Department

was set up with the belief of becoming

the professional supplier of In Vitro

Diagnostic Solutions worldwide. 

Nanjing Vazyme Biotech Co.,Ltd.

2016

IVD Business

Vazyme Medical Technology CO.,

LTD was established, which aimed

to deploy IVD testing reagents and

instruments. 

Nanjing Vazyme Biotech Co.,Ltd.

2019

Biomedical Business

Several key projects of Vazyme

Medical passed the External Quality

Assessment (EQA) of the National

Center for Clinical Laboratories with

full marks. 

Nanjing Vazyme Biotech Co.,Ltd.

2020

Response to COVID-19

COVID-19 Solutions with high detection

sensitivity were developed by Vazyme

professional team and certified by

more and more regions from all over

the world. 

Nanjing Vazyme Biotech Co.,Ltd.

2021

Listed on SSE

Vazyme went public on the star market

of the Shanghai Stock Exchange under

the stock code 688105.

Nanjing Vazyme Biotech Co.,Ltd.

2022

Together for Future

Vazyme ranked among the top 500 listed companies in China in 2021, and was ISO 13485 certified. Also, a new branch was established in German to deliver a full range of solutions locally.

Nanjing Vazyme Biotech Co.,Ltd.

In more than 60 countries and regions worldwide that's where we are present, making sure we are close to our

customers to provide our products, solutions, and services locally. We have four branches in Indonesia, United States,

Germany and HongKong SAR of China, with several warehouses and offices to ensure the worldwide logistics.
NA·LA·EU·MEA·APAC

    

    

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

In more than 60 countries and regions worldwide that's where we are present, making sure we are close to our customers to provide our products, solutions, and services locally. We have three branches in Indonesia, United States, and HongKong SAR of China, with several warehouses and offices to ensure the worldwide logistics.

 

Partners

  • 200

    +

    Pharmaceutical Companies

  • 700

    +

    Gene Sequenceing Service Companies

  • 1000

    +

    Molecular Diagnostics Companies

  • 1000

    +

    Scientific Research Institutes

  • 2200

    +

    Medical and Physical Examination Institutes

  • 200

    +

    Pharmaceutical Companies

  • 700

    +

    Gene Sequenceing Service Companies

  • 1000

    +

    Molecular Diagnostics Companies

  • 1000

    +

    Scientific Research Institutes

  • 2200

    +

    Medical and Physical Examination Institutes

这是描述信息

E-mail:service.biotech@vazyme.com (For Biotech Business)  service.medical@vazyme.com (For Medical Business)                                                     marketing@vazyme.com (Marketing)
© 2022 Nanjing Vazyme Biotech Co.,Ltd.   备案号:
苏ICP备12014779号-1   Power by: 300.cn   SEO


Stock Code:688105.SH

这是描述信息

service.biotech@vazyme.com(For Biotech Business)
service.medical@vazyme.com (For Medical Business)

 marketing@vazyme.com (marketing)
© 2022 Nanjing Vazyme Biotech Co.,Ltd. 

备案号:苏ICP备12014779号-1 Power by: 300.cn  SEO